Literature DB >> 9727849

Cerebrospinal fluid shunts in the management of behavioural problems in Sanfilippo syndrome (MPS III).

S P Robertson1, G L Klug, J G Rogers.   

Abstract

UNLABELLED: Severe behavioural disturbance is a very common feature of Sanfilippo syndrome (mucopolysaccharidosis III, MPSIII), and one of the more difficult aspects of the disease to treat. We describe a series of six patients with MPS III who had cerebrospinal shunts inserted in an attempt to ameliorate behaviour that had proved refractory to conventional treatment. Symptoms improved significantly in all six but removal of the shunt was necessitated in one patient due to shunt blockage and infection.
CONCLUSION: Our experience suggests cerebrospinal fluid shunting should be formally evaluated as an adjunct to conventional forms of treatment of extreme behavioural disturbance in MPS III.

Entities:  

Mesh:

Year:  1998        PMID: 9727849     DOI: 10.1007/s004310050904

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

Review 1.  Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?

Authors:  Amauri Dalla Corte; Carolina F M de Souza; Maurício Anés; Roberto Giugliani
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

2.  Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome.

Authors:  Michael Potegal; Brianna Yund; Kyle Rudser; Alia Ahmed; Kate Delaney; Igor Nestrasil; Chester B Whitley; Elsa G Shapiro
Journal:  J Clin Exp Neuropsychol       Date:  2013-06-08       Impact factor: 2.475

3.  Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.

Authors:  Elsa G Shapiro; Igor Nestrasil; Alia Ahmed; Andrew Wey; Kyle R Rudser; Kathleen A Delaney; Robin K Rumsey; Patrick A J Haslett; Chester B Whitley; Michael Potegal
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

4.  Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.

Authors:  Mark J Osborn; Ron T McElmurry; Brandon Peacock; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2008-06-03       Impact factor: 11.454

5.  Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II.

Authors:  L Vedolin; I V D Schwartz; M Komlos; A Schuch; A C Puga; L L C Pinto; A P Pires; R Giugliani
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.